Why hasn't eliminating acute rejection improved graft survival?

Area of Science:

• Nephrology
• Transplantation Immunology
• Immunosuppression

Background:

• Renal transplantation is the preferred renal replacement therapy for end-stage renal disease due to superior patient survival compared to dialysis.
• Potent immunosuppressive therapies, notably calcineurin inhibitors, have significantly decreased acute rejection rates post-transplantation.

Purpose of the Study:

• To analyze the impact of acute rejection on long-term renal allograft survival.
• To identify other critical factors contributing to late allograft loss.

Main Methods:

• Review of literature on renal transplantation outcomes.
• Analysis of factors influencing long-term allograft survival, including immunosuppression-related toxicities and specific nephropathies.
• Examination of donor and recipient characteristics associated with graft longevity.

Main Results:

• Acute rejection episodes negatively affect long-term allograft survival.
• Calcineurin inhibitor toxicity, chronic allograft nephropathy, and BK virus nephropathy are significant causes of late graft loss.
• Specific donor and recipient factors are associated with reduced long-term allograft survival.

Conclusions:

• Despite advances in immunosuppression, long-term renal allograft survival remains a challenge.
• Addressing calcineurin inhibitor toxicity, chronic allograft nephropathy, and viral infections is crucial for improving graft longevity.
• Optimizing donor and recipient selection and management is essential for maximizing long-term transplant success.